Practice Management System市場は、予測期間(2021年~2026年)に8.3%のCAGRを記録すると予想されています。
というのも、COVID-19に感染した患者が急増しており、これらのソリューションが治療プロセスにおける円滑なワークフローを支援することが期待されているからです…
The polymerase chain reaction market was valued at approximately USD 5,170.37 million in 2020, and it is expected to reach USD 8,094 million by 2026, registering a CAGR of 7.83% during the forecast period, 2021-2026.
The major factors driving the growth …
The hospital information systems market is projected to grow at a CAGR of 8.4% during the forecast period.
The ongoing pandemic is putting healthcare systems under strain worldwide and forcing hospitals and other medical facilities to scramble to make su…
The global molecular diagnostics market was valued at USD 9,371 million in 2020, and it is expected to reach 15,196 million by 2026, registering a CAGR of 9.2% during the forecast period.
Globally, the integrated supply chains that ensure better quality,…
The global in-vitro diagnostics market was valued at approximately USD 68,410 million in 2020, and it is expected to witness a revenue of USD 91,250 million in 2026, with a CAGR of 4.90% over the forecast period.
The COVID-19 pandemic turned the spotligh…
The global veterinary services market was valued at about USD 101,150 million in 2020, and it is expected to reach 140,285 million in 2026, with a CAGR of 5.5% over the forecast period.
Due to the recent outbreak of COVID-19, a short-term negative impact…
The global MEMS sensors market was valued at USD 11,686.2 million in 2020 and is expected to reach USD 16,857.0 million by 2026, registering a CAGR of 6.5% during the forecast period (2021-2026). Due to the COVID-19 pandemic, certain types of MEMS sensors…
The genetic testing market was valued at approximately USD 7,836 million in 2020, and it is expected to witness a revenue of USD 14,227 million in 2026, with a CAGR of 10.45% over the forecast period.
The COVID-19 pandemic has left a significant impact o…
The Biobanks Market is expected to register a CAGR of nearly 9.2% during the forecast period.
The COVID-19 pandemic highlights the risks associated with the collection and processing of human biospecimens with an unknown status for the coronavirus SARS-C…
The Germany In-Vitro Diagnostic Market was valued at USD 3,709.12 million in 2020, and it is expected to reach USD 5,264.97 million by 2026, registering a CAGR of 5.63%, during the period of 2020-2026.
In Germany, due to the COVID-19 pandemic, the demand…